PROVECTUS BIOPHARMACEUTICALS, INC. Equity Distribution Agreements

7 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities Registered Under Section 12 of the Exchange Act – Provectus Biopharmaceuticals, Inc.
Equity Distribution Agreements
PROVECTUS BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2025
Description of Securities Registered Under Section 12 of the Exchange Act – Provectus Biopharmaceuticals, Inc.
Equity Distribution Agreements
PROVECTUS BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2024
Description of Securities Registered Under Section 12 of the Exchange Act – Provectus Biopharmaceuticals, Inc.
Equity Distribution Agreements
PROVECTUS BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2023
Description of Securities Registered Under Section 12 of the Exchange Act – Provectus Biopharmaceuticals, Inc.
Equity Distribution Agreements
PROVECTUS BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2022
Description of Securities Registered Under Section 12 of the Exchange Act – Provectus Biopharmaceuticals, Inc.
Equity Distribution Agreements
PROVECTUS BIOPHARMACEUTICALS, INC.
Pharmaceuticals
2020
Placement Agent Agreement between Provectus Biopharmaceuticals, Inc. and Maxim Group LLC (August 25, 2016)
Equity Distribution Agreements
PROVECTUS BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2016
Controlled Equity Offering Sales Agreement between Provectus Biopharmaceuticals, Inc. and Cantor Fitzgerald & Co.
Equity Distribution Agreements
PROVECTUS BIOPHARMACEUTICALS, INC.
Pharmaceuticals
NY
2014